Why technology standards are critical for Quantum-Safe Security

Safeguard Insights

March 3, 2011

Safeguard Scientifics Fourth Quarter and Year-End Financial Results Recap, Highlighting Aggregate Partner Company Revenue Growth, Acquisitions and IPOs

This morning, we announced our fourth quarter and year-end 2010 financial results. In 2010, our aggregate partner company revenue was $403 million, up 54 percent…

Posted by John E. Shave III

January 13, 2011

Communicating Value and Increasing Transparency

Cash on our balance sheet may be growing with every well-timed exit transaction and positive momentum is driving Safeguard’s stock price upward; however, our IR…

Posted by John E. Shave III

November 3, 2010

Aggregate Partner Company Revenue up 73% in Q3; Guidance Increased to between $360 Million to $385 Million

Earlier today in our third quarter results conference call, we announced that our aggregate partner company revenue increased 73 percent in Q3, and that for…

Posted by John E. Shave III

November 1, 2010

NuPathe Submits Zelrix NDA for the Treatment of Migraine

Safeguard Scientifics’ partner company NuPathe submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA). The NDA was filed for ZelrixTM,…

Posted by James A. Datin

October 7, 2010

Safeguard Scientifics Investor Day 2010 Recap

Thank you to those who were able to attend Safeguard Scientifics’ Investor Day 2010 either in person or via webcast. For those of you were…

Posted by John E. Shave III

September 30, 2010

Reminder: Safeguard Scientifics Investor Day 2010

Just a quick reminder that Safeguard Scientifics’ Investor Day 2010 event will be held next Tuesday, October 5, from 8:00 a.m. – 11:30 a.m. at…

Posted by John E. Shave III

September 14, 2010

Safeguard Scientifics Investor Day 2010

On Tuesday, Oct. 5, Safeguard Scientifics will be hosting Investor Day 2010 from 8 a.m. to 11:30 a.m. EDT at The Yale Club of New…

Posted by John E. Shave III

August 26, 2010

Safeguard CEO featured on TheStreet.com

Last week, Safeguard Scientifics’ President and CEO Peter J. Boni sat down with Gregg Greenberg of TheStreet.com to discuss the emergence of IPO candidates from…

Posted by John E. Shave III

August 16, 2010

IPOs: A Financing Event

On the heels of continued IPO activity, there has been a flurry of media coverage — both positive and negative — regarding the companies that…

Posted by Peter J. Boni

Content